Terms: = Endocrine gland cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Clinical Outcome
4 results:
1. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
[TBL] [Abstract] [Full Text] [Related]
2. Skull Base Tumors: Neuropathology and clinical Implications.
Bi WL; Santagata S
Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
[TBL] [Abstract] [Full Text] [Related]
3. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract] [Full Text] [Related]
4. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
Thompson LD; Wieneke JA; Heffess CS
Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
[TBL] [Abstract] [Full Text] [Related]
